Clinical Trial Update: An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

View source ↗

Summary

Clinical trial update describing an exploratory study comparing mFOLFOX6 plus bevacizumab vs mFOLFOX6 plus panitumumab as first-line therapy in chemotherapy-naï…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• MFOLFOX6
• Panitumumab (panitumumab)

Snippet

Sponsor: Takeda | Conditions: Colorectal Cancer | Status: ACTIVE_NOT_RECRUITING